The Board of Directors of Jiangsu Kanion Pharmaceutical Co.,Ltd. has authorized a buyback plan on February 6, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.53 CNY | -0.23% | -0.74% | -14.57% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.57% | 1.41B | |
+42.69% | 749B | |
+38.73% | 605B | |
-6.87% | 351B | |
+18.74% | 328B | |
+6.76% | 292B | |
+18.87% | 248B | |
-2.29% | 214B | |
+11.25% | 216B | |
+2.64% | 167B |
- Stock Market
- Equities
- 600557 Stock
- News Jiangsu Kanion Pharmaceutical Co.,Ltd.
- Jiangsu Kanion Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.